STOCK TITAN

[Form 4] Broadcom Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Broadcom Inc. (AVGO) director Justine F. Page sold 800 shares of Broadcom common stock at $307.46 per share on 08/14/2025 under a pre-established Rule 10b5-1 trading plan. After the sale the reporting person beneficially owned 23,782 shares, which the filing notes include 1,602 restricted stock units. The transaction was reported on Form 4 and executed pursuant to a trading plan adopted January 9, 2025.

The Form 4 identifies the reporting person as a director and shows the sale was made under code S(1) with an attorney-in-fact signing the filing on behalf of the reporting person. No derivative transactions or other securities classes are reported.

Justine F. Page, membro del consiglio di Broadcom Inc. (AVGO), ha venduto 800 azioni ordinarie Broadcom al prezzo di $307,46 per azione il 14/08/2025, nell'ambito di un piano di negoziazione Rule 10b5-1 predefinito. Dopo la vendita, la soggetta dichiarazione risultava titolare effettiva di 23.782 azioni, comprensive di 1.602 unità azionarie vincolate secondo quanto riportato nel deposito. L'operazione è stata segnalata sul Modulo 4 ed eseguita conformemente al piano di negoziazione adottato il 9 gennaio 2025.

Il Modulo 4 identifica la dichiarante come direttrice e indica che la vendita è avvenuta con il codice S(1), con un procuratore legale che ha firmato il deposito per conto della dichiarante. Non sono riportate transazioni su strumenti derivati né altre classi di titoli.

Justine F. Page, directora de Broadcom Inc. (AVGO), vendió 800 acciones ordinarias de Broadcom a $307.46 por acción el 14/08/2025 bajo un plan de negociación Rule 10b5-1 preestablecido. Tras la venta, la persona informante poseía de forma beneficiosa 23.782 acciones, que el informe señala incluyen 1.602 unidades de acciones restringidas. La operación se notificó en el Formulario 4 y se ejecutó conforme al plan de negociación adoptado el 9 de enero de 2025.

El Formulario 4 identifica a la persona informante como directora y muestra que la venta se realizó bajo el código S(1), con un apoderado que firmó la presentación en nombre de la informante. No se informan transacciones sobre derivados ni otras clases de valores.

Broadcom Inc.(AVGO) 이사 Justine F. Page는 2025년 8월 14일 사전 설정된 Rule 10b5-1 거래 계획에 따라 Broadcom 보통주 800주를 주당 $307.46에 매도했습니다. 매도 후 보고자는 총 23,782주를 실질적으로 보유하고 있었으며, 보고서에는 이 중 1,602주가 제한부 주식 단위(RSU)에 해당한다고 기재되어 있습니다. 이 거래는 Form 4로 보고되었고 2025년 1월 9일에 채택된 거래 계획에 따라 실행되었습니다.

Form 4에는 보고자가 이사로 표기되어 있으며, 해당 매도는 코드 S(1)으로 처리되었고 보고서에는 대리인이 보고서를 대신 서명한 것으로 나와 있습니다. 파생상품 거래나 다른 종류의 증권 거래는 보고되지 않았습니다.

Justine F. Page, administratrice de Broadcom Inc. (AVGO), a vendu 800 actions ordinaires de Broadcom au prix de 307,46 $ par action le 14/08/2025 dans le cadre d'un plan de négociation Rule 10b5-1 préétabli. Après la vente, la personne déclarante détenait effectivement 23 782 actions, le dossier indiquant que 1 602 de ces actions sont des unités d'actions restreintes (RSU). La transaction a été signalée sur le Formulaire 4 et exécutée en vertu d'un plan de négociation adopté le 9 janvier 2025.

Le Formulaire 4 identifie la personne déclarante comme administratrice et indique que la vente a été réalisée sous le code S(1), avec un mandataire ayant signé la déclaration au nom de la déclarante. Aucune transaction portant sur des produits dérivés ni sur d'autres catégories de titres n'est signalée.

Justine F. Page, Direktorin von Broadcom Inc. (AVGO), verkaufte am 14.08.2025 im Rahmen eines vorab eingerichteten Rule-10b5-1-Handelsplans 800 Stammaktien von Broadcom zum Preis von $307,46 je Aktie. Nach dem Verkauf hielt die meldende Person wirtschaftlich 23.782 Aktien, wobei die Einreichung angibt, dass davon 1.602 Restricted Stock Units sind. Die Transaktion wurde in Formular 4 gemeldet und gemäß dem am 9. Januar 2025 angenommenen Handelsplan ausgeführt.

Das Formular 4 identifiziert die meldende Person als Direktorin und weist aus, dass der Verkauf unter dem Code S(1) erfolgte, wobei ein Bevollmächtigter die Einreichung im Namen der meldenden Person unterschrieb. Es werden keine Derivatgeschäfte oder andere Wertpapierklassen gemeldet.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine insider sale executed under a 10b5-1 plan; holdings remain substantial at 23,782 shares.

The sale of 800 shares at $307.46 under a Rule 10b5-1 plan is a procedural disclosure rather than an operational development. The pre-established plan and the attorney-in-fact signature reduce the likelihood the sale signals undisclosed company-specific information. The remaining beneficial ownership, including 1,602 restricted stock units, means the director retains exposure to Broadcom equity, so this filing alone is unlikely to materially change investor valuation assumptions.

TL;DR: Compliance appears in order; transaction follows an adopted 10b5-1 plan and was properly reported on Form 4.

The Form 4 discloses the relationship (director), the trading-plan origin date (January 9, 2025), and that the sale occurred pursuant to that plan. The filing was signed by an attorney-in-fact, consistent with delegated reporting. From a governance perspective, the disclosure meets Section 16 reporting requirements and shows use of standard trading-plan protections against insider trading liability.

Justine F. Page, membro del consiglio di Broadcom Inc. (AVGO), ha venduto 800 azioni ordinarie Broadcom al prezzo di $307,46 per azione il 14/08/2025, nell'ambito di un piano di negoziazione Rule 10b5-1 predefinito. Dopo la vendita, la soggetta dichiarazione risultava titolare effettiva di 23.782 azioni, comprensive di 1.602 unità azionarie vincolate secondo quanto riportato nel deposito. L'operazione è stata segnalata sul Modulo 4 ed eseguita conformemente al piano di negoziazione adottato il 9 gennaio 2025.

Il Modulo 4 identifica la dichiarante come direttrice e indica che la vendita è avvenuta con il codice S(1), con un procuratore legale che ha firmato il deposito per conto della dichiarante. Non sono riportate transazioni su strumenti derivati né altre classi di titoli.

Justine F. Page, directora de Broadcom Inc. (AVGO), vendió 800 acciones ordinarias de Broadcom a $307.46 por acción el 14/08/2025 bajo un plan de negociación Rule 10b5-1 preestablecido. Tras la venta, la persona informante poseía de forma beneficiosa 23.782 acciones, que el informe señala incluyen 1.602 unidades de acciones restringidas. La operación se notificó en el Formulario 4 y se ejecutó conforme al plan de negociación adoptado el 9 de enero de 2025.

El Formulario 4 identifica a la persona informante como directora y muestra que la venta se realizó bajo el código S(1), con un apoderado que firmó la presentación en nombre de la informante. No se informan transacciones sobre derivados ni otras clases de valores.

Broadcom Inc.(AVGO) 이사 Justine F. Page는 2025년 8월 14일 사전 설정된 Rule 10b5-1 거래 계획에 따라 Broadcom 보통주 800주를 주당 $307.46에 매도했습니다. 매도 후 보고자는 총 23,782주를 실질적으로 보유하고 있었으며, 보고서에는 이 중 1,602주가 제한부 주식 단위(RSU)에 해당한다고 기재되어 있습니다. 이 거래는 Form 4로 보고되었고 2025년 1월 9일에 채택된 거래 계획에 따라 실행되었습니다.

Form 4에는 보고자가 이사로 표기되어 있으며, 해당 매도는 코드 S(1)으로 처리되었고 보고서에는 대리인이 보고서를 대신 서명한 것으로 나와 있습니다. 파생상품 거래나 다른 종류의 증권 거래는 보고되지 않았습니다.

Justine F. Page, administratrice de Broadcom Inc. (AVGO), a vendu 800 actions ordinaires de Broadcom au prix de 307,46 $ par action le 14/08/2025 dans le cadre d'un plan de négociation Rule 10b5-1 préétabli. Après la vente, la personne déclarante détenait effectivement 23 782 actions, le dossier indiquant que 1 602 de ces actions sont des unités d'actions restreintes (RSU). La transaction a été signalée sur le Formulaire 4 et exécutée en vertu d'un plan de négociation adopté le 9 janvier 2025.

Le Formulaire 4 identifie la personne déclarante comme administratrice et indique que la vente a été réalisée sous le code S(1), avec un mandataire ayant signé la déclaration au nom de la déclarante. Aucune transaction portant sur des produits dérivés ni sur d'autres catégories de titres n'est signalée.

Justine F. Page, Direktorin von Broadcom Inc. (AVGO), verkaufte am 14.08.2025 im Rahmen eines vorab eingerichteten Rule-10b5-1-Handelsplans 800 Stammaktien von Broadcom zum Preis von $307,46 je Aktie. Nach dem Verkauf hielt die meldende Person wirtschaftlich 23.782 Aktien, wobei die Einreichung angibt, dass davon 1.602 Restricted Stock Units sind. Die Transaktion wurde in Formular 4 gemeldet und gemäß dem am 9. Januar 2025 angenommenen Handelsplan ausgeführt.

Das Formular 4 identifiziert die meldende Person als Direktorin und weist aus, dass der Verkauf unter dem Code S(1) erfolgte, wobei ein Bevollmächtigter die Einreichung im Namen der meldenden Person unterschrieb. Es werden keine Derivatgeschäfte oder andere Wertpapierklassen gemeldet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
PAGE JUSTINE

(Last) (First) (Middle)
C/O BROADCOM INC.
3421 HILLVIEW AVENUE

(Street)
PALO ALTO CA 94304

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Broadcom Inc. [ AVGO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/14/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, $0.001 par value 08/14/2025 S(1) 800 D $307.46 23,782(2) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Transaction made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 9, 2025.
2. Includes 1,602 restricted stock units.
Remarks:
/s/ Noelle Matteson, Attorney-in-Fact for Justine F. Page 08/15/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Justine F. Page report on Form 4 for AVGO?

The Form 4 reports a sale of 800 shares of Broadcom common stock at $307.46 per share on 08/14/2025 executed under a Rule 10b5-1 trading plan.

How many Broadcom (AVGO) shares does the reporting person own after the transaction?

The filing shows beneficial ownership of 23,782 shares following the reported sale, which includes 1,602 restricted stock units.

Was the sale by Justine F. Page part of a trading plan?

Yes. The sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 9, 2025.

What relationship does the reporting person have to Broadcom (AVGO)?

The Form 4 indicates the reporting person is a Director of Broadcom Inc.

Who signed the Form 4 reporting Justine F. Page’s transaction?

The Form 4 was signed by Noelle Matteson, identified as Attorney-in-Fact for Justine F. Page on 08/15/2025.
Broadcom Inc

NASDAQ:AVGO

AVGO Rankings

AVGO Latest News

AVGO Latest SEC Filings

AVGO Stock Data

1.45T
4.61B
2.02%
79.18%
1.01%
Semiconductors
Semiconductors & Related Devices
Link
United States
PALO ALTO